dokumendiregister.ee
Sissetulev kiriAvalik

Küsimused

Ravimiamet · 28. märts 2025
Viit
MSO-8/1634-1
Registreeritud
28. märts 2025
Dokumendi liik
Sissetulev kiri
Adressaat
Abbott Medical
Saabumis/saatmisviis
e-post
Funktsioon
MSO Meditsiiniseadmed
Sari
MSO-8 Turujärelevalvega seotud nõustamine
Toimik
MSO-8/2025
Vastutaja
Maarika Ojala (RA, Meditsiiniseadmete osakond)

Failid

Sisu (failidest)

Saatja: Gilbertson, Michael L <[email protected]> Saaja: Ravimiamet, MSO (Arhiiv), RA MSO, Jiwatrakan, Pin Teema: Abbott Medical - Responsibility for Medical Devices in Estonia Dear Sir/Madam, We have recently become aware that from 01-Jan-2025 the administrative responsibilities of the Estonian Health Board related to medical devices have been transferred to the Estonian State Agency of Medicines. As a Medical Device Manufacturer, to avoid any missed responsibilities of ours. Please can we ask for your support/response to the following questions? 1. Was there a time period where both the old ([email protected] <mailto:[email protected]> ) and new ([email protected] <mailto:[email protected]> ) are active at the same time? If so, what is the timeframe? 2. Has the [email protected] <mailto:[email protected]> email been decommissioned? If so, should we resubmit reports from 01-Jan-2025 until the present day to [email protected] <mailto:[email protected]> ? I look forward to your response. Kind regards, Luke Luke Gilbertson Senior Regulatory Compliance Specialist (EMEA) Abbott, Elder House Blythe Valley Business Park Solihull, UK, B90 8AJ O: -- M: +44 (0) 7785 692 474 E: [email protected] <mailto:[email protected]> [email protected] <mailto:[email protected]>
Allikas: Ravimiamet dokumendiregister →